Stopped: Submission process abandoned. No patient enrolled.
Postoperative management of oral anticoagulation is a frequent preoccupation in cardiac surgery, concerning about half of patients. Vitamin K antagonists are often recommended but their management is not easy due to the high dose-response patient variability. Pharmacologically more stable, direct oral anticoagulants have similar efficiency in preventing thromboembolic complications while they decrease the risk of bleeding in certain patient populations. The objective of study is to assess the safety and efficacy of direct oral anticoagulants in the postoperative period of cardiac surgical procedures.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Hemorrhagic events with anticoagulant treatment
Timeframe: Evaluation at month 3 after hospital discharge for all the postoperative period
Ischemic events with anticoagulant treatment
Timeframe: Evaluation at month 3 after hospital discharge for all the postoperative period
Death with anticoagulant treatment
Timeframe: Evaluation at month 3 after hospital discharge for all the postoperative period
Quality of life with anticoagulant treatment
Timeframe: Evaluation at month 3 after hospital discharge for the last month
Statisfaction of the anticoagulant treatment
Timeframe: Evaluation at month 3 after hospital discharge for the last month